Blog Archives

MED-EL Announces U.S. Launch of New MAESTRO™ Cochlear Implant System

September 13, 2011
By
MED-EL Announces U.S. Launch of New MAESTRO™ Cochlear Implant System

DURHAM, N.C.–NEWS–The MED-EL Corporation announced today the U.S. launch of the new MAESTRO™ Cochlear Implant (CI) System, featuring the MED-EL CONCERT. Implant centers can now begin placing orders for the new system.

Read more »

Merck Statement on GARDASIL®

September 13, 2011
By
Merck Statement on GARDASIL®

WHITEHOUSE STATION, N.J.–NEWS–Merck (NYSE:MRK), known as MSD outside the United States and Canada, issued the following statement on GARDASIL® , Merck’s vaccine to protect against certain diseases caused by human papillomavirus (HPV) types 6, 11, 16 and 18. The facts about GARDASIL are clear....

Read more »

ProFibrix voltooit inschrijving van fase II-studies met leidend haemostase-product Fibrocaps TM en plant start van fase III in H1 2012

September 13, 2011
By
ProFibrix voltooit inschrijving van fase II-studies met leidend haemostase-product Fibrocaps TM en plant start van fase III in H1 2012

LEIDEN, Nederland & SEATTLE–NEWS–ProFibrix B.V., een leider in de ontwikkeling van innovatieve producten voor haemostase, heeft vandaag aangekondigd dat het de inschrijving van patiënten heeft voltooid voor haar twee (Amerikaanse en Nederlandse) prospectieve, gerandomiseerde, gecontroleerde, multi-center fase II-studies met hoofdproduct Fibrocaps in chirurgische haemostase. Jan Ohrstrom, CEO van ProFibrix verklaarde: “We zijn erg blij...

Read more »

AHF Hosts Third “Die-in” Protest Over Gilead’s AIDS Drug Prices

September 13, 2011
By
AHF Hosts Third “Die-in” Protest Over Gilead’s AIDS Drug Prices

SAN FRANCISCO–NEWS–AIDS advocates will participate in a “die-in” protest hosted by AIDS Healthcare Foundation (AHF), tomorrow, Wednesday, September 14th at 8:00 AM outside Gilead Sciences Inc.’s headquarters.

Read more »

CORRECTING and REPLACING Thrasos Initiates Phase 1 Clinical Trial for THR-184 in Acute Kidney Injury

September 13, 2011
By
CORRECTING and REPLACING Thrasos Initiates Phase 1 Clinical Trial for THR-184 in Acute Kidney Injury

MONTREAL–NEWS–Thrasos today announced that it has initiated a Phase 1 clinical trial to study the safety and tolerability of THR-184 for the treatment of Acute Kidney Injury (AKI).

Read more »

Genmed Prepares for Initial Shipments to Distributors; Hires New Sales Manager for European Market

September 13, 2011
By
Genmed Prepares for Initial Shipments to Distributors; Hires New Sales Manager for European Market

AMSTERDAM–NEWS–Genmed Holding Corp. (OTCBB: GENM) has announced that in preparation for its initial shipments to its distributors the Company has made an addition to its management team. The Company hired Dr. Frank A. Bodaan as its dedicated sales manager for the European market. “The addition of Dr. Bodaan comes at a critical time in...

Read more »

Mead Johnson Nutrition Company ANNOUNCES INVESTOR DAY on October 13, 2011

September 13, 2011
By
Mead Johnson Nutrition Company ANNOUNCES INVESTOR DAY on October 13, 2011

CHICAGO–NEWS–You are cordially invited to attend Mead Johnson’s Investor Day event on Thursday, October 13, 2011. The event will feature presentations by the company’s senior executives: Steve Golsby – President and Chief Executive OfficerPete Leemputte – Senior Vice President and CFOKasper Jakobsen – President, AmericasCharles Urbain – President, Asia and EuropeJeff Jobe – Senior Vice...

Read more »

Theragenics’ M. Christine Jacobs Named Co-Chair of New SEC Advisory Committee on Small and Emerging Companies

September 13, 2011
By
Theragenics’ M. Christine Jacobs Named Co-Chair of New SEC Advisory Committee on Small and Emerging Companies

BUFORD, Ga.–NEWS–Theragenics’ CEO Christine Jacobs appointed co-chair of SEC’s new Advisory Committee on Small and Emerging Companies.

Read more »

John Sperzel Appointed as Chief Executive Officer of ITC Nexus Dx

September 13, 2011
By
John Sperzel Appointed as Chief Executive Officer of ITC Nexus Dx

EDISON, N.J.–NEWS–ITC Nexus Dx, a global provider of Point-of-Care testing systems and advanced diagnostic solutions, is pleased to announce the appointment of John Sperzel as Chief Executive Officer, reporting to ITC Nexus’ Board of Directors. The appointment is effective on September 6, 2011. Mr. Sperzel is a dynamic business leader with an outstanding track...

Read more »

Social Media Residency Caps Social Media Week at Mayo Clinic

September 13, 2011
By
Social Media Residency Caps Social Media Week at Mayo Clinic

ROCHESTER, Minn.–NEWS–A week of health care social media learning and networking activities hosted by the Mayo Clinic Center for Social Media will culminate in the center’s first Social Media Residency, Oct. 20–21, 2011 in Rochester. The Social Media Residency uses a medical residency metaphor, complete with residency matching, chief residents, rounding and rotations covering...

Read more »